Cathie Wood's position in Veracyte is currently worth $140 Million. That's 1.11% of their equity portfolio (27th largest holding). The investor owns 9.69% of the outstanding Veracyte stock. The first Veracyte trade was made in Q4 2016. Since then Cathie Wood bought shares eighteen more times and sold shares on nine occasions. The investor's estimated purchase price is $185 Million, resulting in a loss of 24%.